Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Topical antibacterial agents.

Peter A Lio1, Elaine T Kaye

  • 1Department of Dermatology, Harvard Medical School, Massachusetts General Hospital, 55 Fruit Street, Bartlett-616, Dermatology, Boston, MA 02114, USA. plio@partners.org

Infectious Disease Clinics of North America
|August 17, 2004
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Assessment and Clinical Management of Patients With Atopic Dermatitis Undergoing Patch Testing: Recommendations From an International Electronic Delphi Consensus.

Dermatitis : contact, atopic, occupational, drug·2026
Same author

Adalimumab Biosimilars and Access Barriers in Dermatology.

Journal of the American Academy of Dermatology·2026
Same author

Update on the Clinical Management of Atopic Dermatitis in the Pediatric Emergency Department.

Pediatric emergency care·2026
Same author

Benefit-risk profile comparison between dupilumab and upadacitinib: a structured benefit-risk assessment of the Heads Up trial.

The Journal of dermatological treatment·2026
Same author

Identifying the Most Relevant Eczema Area and Severity Index Thresholds from the Patient Perspective in Atopic Dermatitis Treatment.

American journal of clinical dermatology·2026
Same author

Inpatient Psychiatric Burden in Adolescents With Atopic Dermatitis.

Pediatric dermatology·2026
Same journal

Prevention and Control of Clostridioides difficile Infection for the Infectious Diseases Clinician.

Infectious disease clinics of North America·2026
Same journal

Infection Control Strategies to Prevent Emergence and Transmission of Resistant Gram-Negative Bacteria.

Infectious disease clinics of North America·2026
Same journal

Preventing the Spread of Tuberculosis in Health Care Settings.

Infectious disease clinics of North America·2026
Same journal

Threats to Success: Principles of Infection Prevention and Control in Health Care Settings, Part 2: Device and Pathogen Management.

Infectious disease clinics of North America·2026
Same journal

Ventilator-Associated Events: Surveillance and Prevention.

Infectious disease clinics of North America·2026
Same journal

Nosocomial Fungal Infections: Epidemiology, Control Strategies, and Prevention of Candida and Other Yeasts.

Infectious disease clinics of North America·2026
See all related articles

Topical antibacterial agents offer reduced toxicity and enhanced efficacy for skin and wound infections. This review examines their use in prophylaxis and treatment.

Area of Science:

  • Pharmacology
  • Dermatology
  • Infectious Diseases

Background:

  • Topical antibacterial agents provide localized treatment with fewer systemic side effects.
  • Advantages include reduced toxicity, ease of administration, and higher drug concentrations at the application site.

Purpose of the Study:

  • To review the literature on topical antibacterial agents for skin and wound infections.
  • To examine specific agents for prophylaxis and treatment of these infections.

Main Methods:

  • Literature review of selected indications for topical antibacterial agents.
  • In-depth examination of specific antimicrobial compounds.

Main Results:

  • Topical agents demonstrate significant benefits in managing skin and wound infections.

Related Experiment Videos

  • Specific agents are effective in both preventing and treating infections.

    • Conclusions:

    • Topical antibacterials are valuable therapeutic options for skin and wound infections.
    • Their use is supported by evidence for prophylaxis and treatment, offering localized benefits.